Search Results
Expert Panel Approves Covaxin Phase 2& 3 Trials For Children Between 2-18 Years
Covaxin clinical trials for children (2 – 18 years) approved by DCGI
Bharat Biotech's Covaxin Recommended By Expert Panel For Phase 2/3 Trials On Children
Coronavirus Vaccine News | Covaxin's Phase 2 And 3 Trials For Kids Soon, Expert Panel Gives Nod
Coronavirus Vaccine News | DCGI Approves Phase 2 And 3 Trials Of Covaxin Of 2-18 Year-Old
Coronavirus Vaccine | Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report
Covid-19 Vaccine For Kids | Covaxin Gets Approval For Phase 2-3 Clinical Trials For 2-18 Age Group
Bharat Biotech’s Covaxin Set For Trials on Children Aged Between 2 -18
Bharat Biotech will begin clinical trial of Covaxin on 2-18 age group
Medical Experts Answer FAQs Over COVAXIN Vaccination Trials On Children Of Age Group 2-18
Bharat Biotech Vaccine Approved For Trial On Children Above 12 Years, Covishield Above Age 18
DCGI Approves Phase II, III Clinical Trials Of COVAXIN For The Age Group Of 2 To 18 Years